by admin | Sep 8, 2023 | Pharmaceutical Litigation
FDA adds Blackbox warning for Hearing Loss. The New Warning Label was added for Tepezza on 7/20/23 which includes warnings not previously provided that potentially indicate a failure to warn initially of all dangers. Tepezza may cause severe hearing impairment... by admin | Sep 7, 2023 | Pharmaceutical Litigation
Have you or a loved one developed Gastroparesis from taking Ozempic? If you or a loved one have experienced gastrointestinal side effects after using Ozempic, which contains the active ingredient semaglutide, you may be entitled to compensation. Often, the side effect... 
by admin | Sep 20, 2022 | News, Zantac Cancer, Consumer Products
Zantac belongs to a group of medications known as histamine-2 blockers. These drugs reduce acid production in the stomach for those diagnosed with gastroesophageal reflux disease (GERD), Zollinger Ellison syndrome, and other conditions causing heartburn and ulcers.... by admin | Aug 25, 2022 | News, Injuries, Roundup, 2 Minute Read
2 min read Introduction The RoundUp Litigation still has over 40,000 unresolved claims by claimants with NHL from being exposed to the herbicide. More plaintiffs are taking to trial to obtain the amount of compensation that they rightly deserve. [1] As of August 15,... by admin | Feb 10, 2022 | 2 Minute Read, News, Pharmaceutical Litigation
What it is We have previously discussed what type of injury that Fournier’s gangrene is, please see the link here. This blog is to clarify the qualifying standard that is currently required due to the August 2018 label change issued by the FDA when they... by admin | Sep 14, 2021 | News, valsartan
FDA Warning On June 13, 2018, the FDA issued a warning that alerted healthcare professionals to contamination in the product Valsartan. The contamination contained “impurities in certain commonly prescribed heart medicines.”[i] Companies Involved Some of the companies...
Recent Comments